| 25.09.2025 13:43 | CTA, POLX, PMP | EARNINGS AND TRADING: Comptoir loss narrows; Journeo profit down | Alliance |
| 25.09.2025 07:00 | N4P | Interim Results | RNS |
| 23.09.2025 18:29 | N4P | IN BRIEF: N4 Pharma teams up with University of Strathclyde facility | Alliance |
| 23.09.2025 07:00 | N4P | Partnership with University of Strathclyde’s CMAC | RNS |
| 22.09.2025 11:02 | OPG, N4P | AIM WINNERS & LOSERS: WH Ireland agrees disposal, proposes wind-down | Alliance |
| 22.09.2025 10:24 | N4P | N4 Pharma surges as Nuvec targets RNA delivery to lung cancer cells | Alliance |
| 22.09.2025 07:00 | N4P | N4 Pharma’s Nuvec® Targets Lung Cancer Cells | RNS |
| 19.09.2025 07:00 | N4P | Notice of Results, Analyst & Investor Presentation | RNS |
| 11.09.2025 07:00 | N4P | Investor Event and Presentation | Reach |
| 30.07.2025 13:55 | N4P | Article on Nuvec®’s Potential in RNA Therapeutics | Reach |
| 14.07.2025 07:00 | N4P | Investor Webinar | Reach |
| 08.07.2025 07:00 | N4P | Directorate Change | RNS |
| 30.06.2025 14:15 | N4P | Result of AGM | RNS |
| 30.06.2025 07:00 | N4P | AGM Statement | RNS |
| 25.06.2025 07:00 | N4P | Insight Event for Retail Investors | Reach |
| 06.06.2025 11:15 | N4P | N4 Pharma loss narrows as awaits FDA decision on glaucoma therapy | Alliance |
| 06.06.2025 07:00 | N4P | Final Results, Annual Report and Notice of AGM | RNS |
| 27.05.2025 07:00 | N4P | Establishment of New Senior Leadership Team | Reach |
| 23.05.2025 12:37 | N4P | TR-1: Notification of major holdings | RNS |
| 21.05.2025 16:11 | N4P | Holding(s) in Company | RNS |
| 15.05.2025 15:13 | N4P | Change of Registered Address | RNS |
| 12.05.2025 11:37 | N4P | N4 Pharma hails positive results in inflammatory bowel disease study | Alliance |
| 12.05.2025 07:00 | N4P | N4 101 In Vivo Study Results | RNS |
| 09.05.2025 08:24 | N4P | Holding(s) in Company | RNS |
| 29.04.2025 16:25 | N4P | Holding(s) in Company | RNS |
| 29.04.2025 11:05 | N4P | Holding(s) in Company | RNS |
| 28.04.2025 14:30 | N4P | Holding(s) in Company | RNS |
| 23.04.2025 14:32 | N4P | TR-1: Standard form notification of major holdings | RNS |
| 22.04.2025 11:56 | N4P | Result of General Meeting | RNS |
| 15.04.2025 14:20 | WBI, N4P, LDG | UK shareholder meetings calendar - next 7 days | Alliance |
| 04.04.2025 07:08 | N4P | Posting of Circular and Notice of General Meeting | RNS |
| 01.04.2025 16:08 | N4P | Placing and Subscription to raise £1,750,000 | RNS |
| 07.02.2025 07:00 | N4P | Investor Webinar | Reach |
| 27.01.2025 07:00 | N4P | Investor Webinar | Reach |
| 16.01.2025 07:00 | N4P | N4 Pharma Non-Executive Director Q&A | Reach |
| 08.01.2025 07:00 | N4P | Directorate Changes | RNS |
| 12.12.2024 10:40 | N4P, VEL, VANL | AIM WINNERS & LOSERS: Velocity Composites expects to beat market view | Alliance |
| 04.12.2024 10:57 | N4P, LIT | AIM WINNERS & LOSERS: Biome warns on revenue; legal blow for LCM | Alliance |
| 04.12.2024 07:00 | N4P | New Patent Filing | RNS |
| 28.11.2024 07:00 | N4P | Grant of Options | RNS |
| 01.11.2024 07:00 | N4P | N4 Pharma CEO Q&A Now LIVE | Reach |
| 24.10.2024 07:00 | N4P | New Corporate Presentation | Reach |
| 24.09.2024 15:01 | N4P, GWI, MET1 | EARNINGS: Metals One advances Black Schist, N4 generates revenue | Alliance |
| 24.09.2024 07:00 | N4P | Interim Results | RNS |
| 17.09.2024 08:04 | N4P | SRI Research Update | RNS |
| 09.09.2024 07:00 | N4P | Director Appointment | RNS |
| 23.08.2024 08:30 | N4P | Change of Auditor | RNS |
| 20.08.2024 11:52 | N4P | IN BRIEF: N4 Pharma celebrates chemistry work update on Nuvec | Alliance |
| 20.08.2024 10:24 | N4P, MBO, SKA | AIM WINNERS & LOSERS: Shuka Minerals down on CLN drawdown | Alliance |
| 20.08.2024 07:00 | N4P | SRI Research Update | RNS |
